These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12146020)

  • 1. Criteria for organized cervical screening programs. Special emphasis on The Netherlands program.
    Hanselaar AG
    Acta Cytol; 2002; 46(4):619-29. PubMed ID: 12146020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical screening revisited.
    van der Graaf Y; Vooijs GP; Zielhuis GA
    Acta Cytol; 1990; 34(3):366-72. PubMed ID: 2111625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of quality assurance in an organized cervical screening program.
    Andrae B; Smith P
    Acta Obstet Gynecol Scand; 1999 May; 78(5):429-35. PubMed ID: 10326890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.
    Rebolj M; van Ballegooijen M; Berkers LM; Habbema D
    Int J Cancer; 2007 Feb; 120(4):806-12. PubMed ID: 17131311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.
    Bos AB; Rebolj M; Habbema JD; van Ballegooijen M
    Int J Cancer; 2006 Nov; 119(10):2372-5. PubMed ID: 16858676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer screening monitoring system: indicators for organised programmes and possible extension to spontaneous screening.
    Giorgi Rossi P; Federici A; Zappa M
    Pathologica; 2013 Jun; 105(3):83-5. PubMed ID: 24047033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cervical cancer screening and follow-up programs.
    Celentano DD; deLissovoy G
    Public Health Rev; 1989-1990; 17(2-3):173-240. PubMed ID: 2518819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workshop on screening for cancer of the uterine cervix in Central America.
    Miller AB; Robles SC
    Bull Pan Am Health Organ; 1996 Dec; 30(4):397-408. PubMed ID: 9041753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective from countries using organized screening programs.
    Miles A; Cockburn J; Smith RA; Wardle J
    Cancer; 2004 Sep; 101(5 Suppl):1201-13. PubMed ID: 15316915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Pap smear quality-assurance system in family practice.
    Curtis P; Varenholt JJ; Skinner B; Addison L; Resnick J; Kebede M
    Fam Med; 1993 Feb; 25(2):135-9. PubMed ID: 8458544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell preparation methods and criteria for sample adequacy. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    McGoogan E; Colgan TJ; Ramzy I; Cochand-Priollet B; Davey DD; Grohs HK; Gurley AM; Husain OA; Hutchinson ML; Knesel EA; Linder J; Mango LJ; Mitchell H; Peebles A; Reith A; Robinowitz M; Sauer T; Shida S; Solomon D; Topalidis T; Wilbur DC; Yamauchi K
    Acta Cytol; 1998; 42(1):25-32. PubMed ID: 9479321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R; Budukh AM; Rajkumar R
    Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
    Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.